Decisive BI
Decisive Consulting, founded in 2020 by Esther Nzenza, emerged as a bold challenger in the life sciences market access space, known for its 'Rebel Thinking' approach to solving complex access and commercialization challenges.
Profile
Decisive Consulting helps life sciences companies navigate global market access and commercialization challenges.
Decisive Consulting, founded in 2020 by Esther Nzenza, emerged as a bold challenger in the life sciences market access space, known for its 'Rebel Thinking' approach to solving complex access and commercialization challenges. The firm quickly gained traction by helping pharmaceutical companies navigate the intricacies of global market access, health economics, and outcomes research (HEOR). In June 2025, Decisive Consulting was acquired by Herspiegel, a leading pharmaceutical commercialization services firm, in a strategic move to expand Herspiegel's global market access capabilities.
The acquisition brought together Decisive's innovative strategies with Herspiegel's established commercialization expertise, creating a comprehensive suite of services spanning early evidence planning through successful product launches. Decisive Consulting had supported over 45 companies since its inception, focusing on portfolio design, HTA strategy, and execution across multiple countries. Post-acquisition, Esther Nzenza remained with Herspiegel as Senior Partner Global Value and Market Access, continuing to lead Decisive's integration into Herspiegel's broader offerings. The acquisition marked a significant step in Herspiegel's strategy to strengthen its position in the global life sciences market, particularly in the face of increasing complexity in market access and commercialization.
Who buys this
- Pharmaceutical companies
- Biotech firms
- Life sciences organizations
- Healthcare providers
- Market access consultants
Strengths and what to watch
Strengths
- Specializes in innovative market access strategies
- Strong expertise in health economics and outcomes research (HEOR)
- Global reach with experience in multiple countries
Watch for
- Integration challenges post-acquisition by Herspiegel
- Potential client churn during transition
- Increased competition in the market access consulting space
Recent moves
Key Information
- Founded
- 2020
Frequently Asked Questions
What does Decisive Consulting do?
Decisive Consulting helps life sciences companies navigate global market access and commercialization challenges. Founded in 2020, it specializes in portfolio design, health economics, and outcomes research (HEOR) strategies. The firm supports pharmaceutical and biotech clients across multiple countries with innovative market access solutions.
Who acquired Decisive Consulting and why?
Herspiegel, a pharmaceutical commercialization services firm, acquired Decisive Consulting in June 2025 to expand its global market access capabilities. The strategic move combined Decisive's innovative approaches with Herspiegel's commercialization expertise, creating comprehensive services from early evidence planning to product launches.
What types of companies use Decisive's services?
Decisive serves pharmaceutical companies, biotech firms, life sciences organizations, healthcare providers, and market access consultants. Its clients require specialized support for global market access strategies, health economics research, and commercialization planning across international markets.
What makes Decisive Consulting different in market access consulting?
Decisive stands out through its 'Rebel Thinking' approach to solving complex access challenges. The firm combines innovative market access strategies with deep health economics expertise, having supported over 45 companies with portfolio design and HTA strategy execution across multiple countries.
What happened to Decisive Consulting after the acquisition?
Post-acquisition, Decisive integrated into Herspiegel's broader offerings while maintaining its specialized focus. Founder Esther Nzenza remained as Senior Partner Global Value and Market Access, ensuring continuity of Decisive's methodologies within Herspiegel's expanded commercialization services.
What challenges might Decisive Consulting face after acquisition?
Potential challenges include integration with Herspiegel's systems, client retention during transition, and increased competition. However, the acquisition provides Decisive with expanded resources and global reach, strengthening its ability to deliver comprehensive market access solutions in the evolving life sciences landscape.
Sources
- www.prnewswire.com — Acquisition of Decisive Consulting by Herspiegel
- www.prnewswire.com — Context on life sciences market dynamics
- www.prnewswire.com — Broader industry trends impacting life sciences
- www.prnewswire.com — Leadership transitions in related industries